Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Induction to Buprenorphine/Naloxone: A Quasi-Experimental Study With Comparison Group

NCT05644587 is registered in ClinicalTrials.gov with Bicycle Health as lead sponsor.

NCT NCT05644587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05644587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Induction to Buprenorphine/Naloxone: A Quasi-Experimental Study With Comparison Group
Lead sponsor
Bicycle Health
Phase
Phase 4
Overall status
Terminated
Start date
February 6, 2023
Completion date
November 30, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid abuse, opioid dependence, opioid misuse, opioid use, opioid use disorder